Matthew Chervenak - Chief Executive Officer
Matthew founded GB in Shanghai in 2002. His areas of focus include strategy development, deal sourcing, due diligence, drug discovery, outsourcing, and industry data. He worked previously at Sapient Corporation in New York City, New York University Medical Center, and the National Institutes of Health. Matthew is the Chairman of American Chamber of Commerce –Shanghai Healthcare Committee.

Contact: mcherv@generalbiologic.com.

Jonathan Zifferblatt, MD, MBA, MPH - Managing Director
Jon joined GB in early 2008. His areas of focus include due diligence, market assessments, practice and prescribing patterns, and healthcare systems and delivery. He has previous experience in management roles in the pharmaceutical and banking industries and is a US-licensed physician. Jon is the Vice-chair of American Chamber of Commerce – Shanghai Healthcare Committee.

Contact: jziff@generalbiologic.com.

Associates and analysts
Our team of associates and analysts is a mix of local and foreign professionals with life science, pharmaceutical, and medical backgrounds. Via daily information gathering and data analysis, the staff maintains a knowledge base that is current with the rapid changes and new developments in the medical and pharmaceutical sectors. With work experience in various parts of the healthcare and pharma value chains, GB team members are able to rapidly locate data, assess information in context, and understand implications for client objectives.